$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Efficacy and safety of entecavir plus carnitine complex (GODEX®) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study 원문보기

Clinical and molecular hepatology, v.19 no.2, 2013년, pp.165 - 172  

Jun, Dae Won (Department of Internal medicine, Hanyang University College of Medicine, Seoul, Korea.) ,  Kim, Byung Ik (Department of Internal Medicine, Kangbuk Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.) ,  Cho, Yong Kyun (Department of Internal Medicine, Kangbuk Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.) ,  Kim, Hong Ju (Department of Internal Medicine, Kangbuk Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.) ,  Kwon, Young Oh (Department of Internal Medicine, Kyungpook National University Hospital, Kyungpook National University College of Medicine, Daegu, Korea.) ,  Park, Soo Young (Department of Internal Medicine, Kyungpook National University Hospital, Kyungpook National University College of Medicine, Daegu, Korea.) ,  Han, Sang Young (Department of Internal Medicine, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Korea.) ,  Baek, Yang Hyun (Department of Internal Medicine, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Korea.) ,  Jung, Yong Jin (Department of Internal M) ,  Kim, Hwi Young ,  Kim, Won ,  Heo, Jeong ,  Woo, Hyun Young ,  Hwang, Seong Gyu ,  Rim, Kyu Sung ,  Choi, Jong Young ,  Bae, Si Hyun ,  Lee, Young Sang ,  Lim, Young Suck ,  Cheong, Jae Youn ,  Cho, Sung Won ,  Lee, Byung Seok ,  Kim, Seok Hyun ,  Sohn, Joo Hyun ,  Kim, Tae Yeob ,  Paik, Yong Han ,  Kim, Ja Kyung ,  Lee, Kwan Sik

Abstract AI-Helper 아이콘AI-Helper

Background/AimsCarnitine and vitamin complex (Godex®) is widely used in patients with chronic liver disease who show elevated liver enzyme in South Korea. The purpose of this study is to identify the efficacy and safety of carnitine from entecavir combination therapy in Alanine aminotransferase ...

주제어

참고문헌 (16)

  1. 1 Chang TT Gish RG de Man R Gadano A Sollano J Chao YC A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B N Engl J Med 2006 354 1001 1010 16525137 

  2. 2 Chon YE Kim SU Lee CK Heo J Kim JK Yoon KT Partial virological response to entecavir in treatment-naive patients with chronic hepatitis B Antivir Ther 2011 16 469 477 21685534 

  3. 3 Park MS Kang JS Jeon JY Baek SW Lim GS Kwak MJ Effectiveness of Godex capsule on chronic liver disease patients J Korean Soc Clin Pharmacol Ther 2001 9 151 162 

  4. 4 Bertelli A Cerrati A Giovannini L Mian M Spaggiari P Bertelli AA Protective action of L-carnitine and coenzyme Q10 against hepatic triglyceride infiltration induced by hyperbaric oxygen and ethanol Drugs Exp Clin Res 1993 19 65 68 8223144 

  5. 5 Bykov I Jarvelainen H Lindros K L-carnitine alleviates alcohol-induced liver damage in rats: role of tumour necrosis factor-alpha Alcohol Alcohol 2003 38 400 406 12915513 

  6. 6 Elliott GR Lauwen AP Bonta IL The effect of acute feeding of carnitine, acetyl carnitine and propionyl carnitine on basal and A23187-stimulated eicosanoid release from rat carrageenan-elicited peritoneal macrophages Br J Nutr 1990 64 497 503 2171633 

  7. 7 Jun DW Cho WK Jun JH Kwon HJ Jang KS Kim HJ Prevention of free fatty acid-induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction Liver Int 2011 31 1315 1324 22093454 

  8. 8 Lim CY Jun DW Jang SS Cho WK Chae JD Jun JH Effects of carnitine on peripheral blood mitochondrial DNA copy number and liver function in non-alcoholic fatty liver disease Korean J Gastroenterol 2010 55 384 389 20571306 

  9. 9 Malaguarnera M Vacante M Bertino G Neri S Malaguarnera M Gargante MP The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-alpha 2b plus ribavirin J Interferon Cytokine Res 2011 31 653 659 21923249 

  10. 10 Malaguarnera M Vacante M Giordano M Motta M Bertino G Pennisi M L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-alpha 2b plus ribavirin World J Gastroenterol 2011 17 4414 4420 22110268 

  11. 11 Romano M Vacante M Cristaldi E Colonna V Gargante MP Cammalleri L L-carnitine treatment reduces steatosis in patients with chronic hepatitis C treated with alpha-interferon and ribavirin Dig Dis Sci 2008 53 1114 1121 17939042 

  12. 12 Athanassakis I Mouratidou M Sakka P Evangeliou A Spilioti M Vassiliadis S L-carnitine modifies the humoral immune response in mice after in vitro or in vivo treatment Int Immunopharmacol 2001 1 1813 1822 11562072 

  13. 13 Hao J Shen W Tian C Liu Z Ren J Luo C Mitochondrial nutrients improve immune dysfunction in the type 2 diabetic Goto-Kakizaki rats J Cell Mol Med 2009 13 701 711 18410524 

  14. 14 Athanassakis I Dionyssopoulou E Papanikou S Evangeliou A Vassiliadis S Early events of the exogenously provided L-Carnitine in murine macrophages, T- and B-lymphocytes: modulation of prostaglandin E1 and E2 production in response to arachidonic acid J Nutr Biochem 2003 14 350 357 12873717 

  15. 15 Liang M Ma S Hu X Zhou B Zhang J Chen J Cellular immune responses in patients with hepatitis B surface antigen seroclearance induced by antiviral therapy Virol J 2011 8 69 21320337 

  16. 16 Joo SS Won TJ Kim MJ Hwang KW Lee DI Interferon signal transduction of biphenyl dimethyl dicarboxylate/amantadine and anti-HBV activity in HepG2 2.2.15 Arch Pharm Res 2006 29 405 411 16756086 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로